The Tuberous Sclerosis Alliance supports the AllTrials initiative to ensure that data from all clinical trials are published in a timely manner.  Publication of clinical trial results can help avoid unnecessary duplication of effort and enables researchers to build on what has been learned from prior trials.  Additionally, publication of clinical trial results acknowledges the value of knowledge gained—regardless of the clinical trial outcome—through the voluntary participation of human subjects.